With the development of targeted therapy, adenocarcinoma are classified into subsets, such as epidermal growth factor receptor (EGFR)-mutated type [3, 4], anaplastic lymphoma kinase (ALK)-rearranged type [5] and ROS1-rearranged type [6]. Here, ROS1 is linked to adenocarcinoma.